Clinical trial
Strategies for Delivering Anti-HIV Therapy in South Africa
NCT00080522 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00080522 |
|---|---|
| Title | Strategies for Delivering Anti-HIV Therapy in South Africa |
| Official title | Safeguard the Household: A Study of HIV Antiretroviral Therapy Treatment Strategies Appropriate for a Resource Poor Country |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral, Drug |
| Interventions | Monitoring by HIV-trained primary care nurses, Community-based directly observed therapy (DOT), stavudine, lamivudine, efavirenz, zidovudine, didanosine, lopinavir/ritonavir |
| Enrollment | 813 |
| Start date | Feb 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Apr 7, 2004 |
| Last update posted | Sep 18, 2007 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: